General Information of This Antigen
Antigen ID
TAR0RZESP
Antigen Name
Signal transducer CD24 (CD24)
Gene Name
CD24
Gene ID
100133941
Synonym
CD24A; Small cell lung carcinoma cluster 4 antigen;CD24
Sequence
MGRAMVARLGLGLLLLALLLPTQIYSSETTTGTSSNSSQSTSNSGLAPNPTNATTKAAGG
ALQSTASLFVVSLSLLHLYS

    Click to Show/Hide
Family
ATR family
Function
May have a pivotal role in cell differentiation of different cell types. Signaling could be triggered by the binding of a lectin- like ligand to the CD24 carbohydrates, and transduced by the release of second messengers derived from the GPI-anchor. Modulates B-cell activation responses. Promotes AG-dependent proliferation of B-cells, and prevents their terminal differentiation into antibody-forming cells. In association with SIGLEC10 may be involved in the selective suppression of the immune response to danger-associated molecular patterns (DAMPs) such as HMGB1, HSP70 and HSP90. Plays a role in the control of autoimmunity.

    Click to Show/Hide
Uniprot Entry
CD24_HUMAN
HGNC ID
HGNC:1645
KEGG ID
hsa:100133941
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
Anti-CD24 G7mAb
ADC Name Payload Target Linker ADC Info
HN-01 [1]
Diazeniumdiolate
Undisclosed
Mc-disulfane based linker
ADC Name Payload Target Linker ADC Info
HN03 [2]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
HN03-A [2]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
HN03-B [2]
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
HN-02 [3]
Undisclosed
Undisclosed
Undisclosed
Undisclosed
ADC Name Payload Target Linker ADC Info
ONC-784 [4]
Undisclosed
Undisclosed
Undisclosed
References
Ref 1 Anti-CD24 Antibody-Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma. Cancer Res. 2019 Jul 1;79(13):3395-3405. doi: 10.1158/0008-5472.CAN-18-2839. Epub 2019 Mar 27.
Ref 2 CD24 antibody-drug conjugates and their preparation and uses
Ref 3 Site-specific Antibody-Nitric Oxide Conjugate HN02 Possesses Improved Antineoplastic and Safety Properties
Ref 4 OncoC4 biopharmaceutical company product pipeline